drugset / Trial / NCT01768767

Trial of Ketamine and Lithium Therapy in Bipolar Depression

NCT01768767 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is looking at the safety and efficacy of combined ketamine and lithium therapy for treating patients with bipolar depression who are taking a mood stabilizer that is not working for them.

Timeline

Start
2013-01
Primary completion
2013-01
Completion
2013-01

Outcome

Outcome not reported

Stopped (Business): “No funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule — —
Subject Lithium Unknown — —

Indications